abberior instruments
2024
BioMed Research International
Two Main Cancer Biomarkers as Molecular Targets of Binase Antitumor Activity
Authors:
Elena Dudkina, Vera Ulyanova, Violetta Asmandiyarova, Valentina Vershinina, Olga Ilinskaya
Keywords:
cancer, MAPK signaling, EGFR, RAS, oncogene, ribonuclease, binase
Abstract:
Cancer is frequently coupled with the disturbance of key signaling pathways. Aberrant activation of the mitogen-activated protein kinase (MAPK) signaling cascade, occurring in over 85% of cancers, is mainly caused by the genetic alterations of its main components—oncogenes EGFR and RAS, and plays a crucial role in cell fate. The importance of EGFR and RAS proteins in a variety of tumors suggests that they would be good therapeutic targets, but at present, no effective targeted therapy against these two oncogenes has been proven. Here, we show that ribonuclease from Bacillus pumilus (binase) inhibits MAPK signaling through direct interaction with EGFR and RAS proteins. This effect contributes to the antitumor potential of binase along with its enzymatic activity. Multitargeticity of binase prevents the development of drug resistance, which is considered a major obstacle to effective anticancer treatment.